Chronic Disease Initiative for Africa, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Biostatistics Unit, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
BMJ Open. 2019 May 22;9(5):e024345. doi: 10.1136/bmjopen-2018-024345.
The aim of this research was to estimate the prevalence of type 2 diabetes mellitus (T2DM), impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), in African women of childbearing age.
Systematic review and meta-analysis of relevant African studies published from January 2000 to December 2016.
We searched several databases, including EMBASE, MEDLINE, CINAHL, grey literature and references of included studies.
Studies carried out in African communities or any population-based studies were included.
We included studies, carried out in Africa, with non-pregnant women of childbearing age. Studies must have been published between the years 2000 and 2016.
The primary outcome was prevalent T2DM. The secondary outcomes were IFG and IGT.
Two reviewers independently extracted data and, using the adapted Hoy risk of bias tool, independently assessed for risk of bias. We used random-effects meta-analysis models to pool prevalence estimates across studies. We used Cochran's Q statistic and the I statistic to assess heterogeneity.
A total of 39 studies from 27 countries were included, totaling 52 075 participants, of which 3813 had T2DM. The pooled prevalence of T2DM was 7.2% (95% CI 5.6% to 8.9%) overall and increased with age. The pooled prevalence was 6.0% (95% CI 4.2% to 8.2%) for impaired fasting glycemia while the prevalence of IGT ranged from 0.9% to 37.0% in women aged 15-24 and 45-54 years, respectively. Substantial heterogeneity across studies was not explained by major studies characteristics such as period of publication, rural/urban setting or whether a study was nationally representative or not.
This review highlights the need for interventions to prevent and control diabetes in African women of childbearing age, in view of the significant prevalence of T2DM and prediabetes.
CRD42015027635.
本研究旨在评估非洲育龄期女性 2 型糖尿病(T2DM)、空腹血糖受损(IFG)和葡萄糖耐量受损(IGT)的患病率。
对 2000 年 1 月至 2016 年 12 月期间发表的相关非洲研究进行系统回顾和荟萃分析。
我们检索了多个数据库,包括 EMBASE、MEDLINE、CINAHL、灰色文献和纳入研究的参考文献。
包括在非洲社区进行的研究或任何基于人群的研究。
我们纳入了在非洲进行的、非妊娠育龄期女性的研究。研究必须在 2000 年至 2016 年之间发表。
主要结局是 T2DM 的流行率。次要结局是 IFG 和 IGT。
两位评审员独立提取数据,并使用改编后的 Hoy 偏倚风险工具独立评估偏倚风险。我们使用随机效应荟萃分析模型来汇总研究间的患病率估计值。我们使用 Cochran's Q 统计量和 I 统计量来评估异质性。
共纳入来自 27 个国家的 39 项研究,共计 52075 名参与者,其中 3813 名患有 T2DM。总体而言,T2DM 的患病率为 7.2%(95%CI 5.6%至 8.9%),且随年龄增长而增加。IFG 的患病率为 6.0%(95%CI 4.2%至 8.2%),而 IGT 的患病率在 15-24 岁和 45-54 岁的女性中分别为 0.9%至 37.0%。研究特征如发表时间、农村/城市环境、研究是否具有全国代表性等并不能解释各研究间的显著异质性。
鉴于 T2DM 和糖尿病前期的高患病率,本研究强调需要在非洲育龄期女性中开展干预措施,以预防和控制糖尿病。
PROSPERO 注册号:CRD42015027635。